Atlas Trials

Evaluate the Efficacy and Safety of EN001 in Patients With Duchenne Muscular Dystrophy

Clinical trial NCT06328725 · UNKNOWN

Trial details

NCT number
NCT06328725
Sponsor
ENCell
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Duchenne Muscular Dystrophy
Start date
2024-03-01
Primary completion
2025-11-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.